Skip to main content

Table 1 Characteristics of study populations by post-RT pain

From: Genome-wide enriched pathway analysis of acute post-radiotherapy pain in breast cancer patients: a prospective cohort study

Variable

Categories

 

Post-RT pain

  

Total

No (score < 4)

Yes (score ≥ 4)

  

N

%

N

%

N

%

p 1

p 2

Study population

 

1112

100

786

71

326

29

  

Study site

UM

377

34

243

64

134

36

0.001

0.340

WFU

735

66

543

74

192

26

  

Race/ethnicity

AA

296

27

194

66

102

34

< 0.001

0.315

HW

401

36

265

66

136

34

  

NHW

357

32

282

79

75

21

  

Other

58

5

45

78

13

22

  

Age at consent (years)

< 50

283

25

175

62

108

38

<.0001

<.0001

50–59

372

34

247

66

125

34

  

≥ 60

457

41

364

80

93

20

  

BMI (kg/m2)

< 25

257

23

208

81

49

19

< .0001

0.002

25–29.99

357

32

263

74

94

26

  

≥ 30

498

45

315

63

183

37

  

Smoking history

Never

706

64

514

73

192

27

0.033

0.026

Ever

390

35

260

67

130

33

  

No. of comorbidity3

0

464

42

337

73

127

27

0.035

0.001

1

378

34

275

73

103

27

  

≥ 2

270

24

174

64

96

36

  

Tumor stage

0

217

20

159

73

58

27

0.077

–

I

528

47

384

73

144

27

  

II

234

21

161

69

73

31

  

III–IV

132

12

82

62

50

38

  

ER

Positive

894

80

632

71

262

29

0.957

–

Negative

217

20

153

71

64

29

  

PR

Positive

767

69

533

69

234

31

0.178

–

Negative

343

31

252

73

91

27

  

HER2

Positive

143

13

106

74

37

26

0.283

–

Negative

798

72

556

70

242

30

  

Triple negative

No

964

87

687

71

277

29

0.248

–

Yes

134

12

89

66

45

34

  

Surgery

Lumpectomy

959

86

698

73

261

27

< .0.001

0.023

Mastectomy

153

14

88

58

65

42

  

Chemotherapy

No

610

55

441

72

169

28

0.193

–

Yes

502

45

345

69

157

31

  

Hormonal therapy

No

785

71

570

73

215

27

0.029

0.587

Yes

327

29

216

66

111

34

  

RT fractionation

Conventional

972

87

670

69

302

31

0.003

0.414

Hypo

138

13

114

83

24

17

  

Partial

2

0.1

2

100

.

.

  

RT dose (Gy)

< 60

266

24

205

77

61

23

0.010

–

≥ 60

834

75

574

69

260

31

  

Boost

No

121

11

94

78

27

22

0.078

–

Yes

979

88

685

70

294

30

  

Pre-RT pain score

< 4

936

84

715

76

221

24

< .0001

< .0001

≥ 4

151

14

57

38

94

62

  
  1. 1p values from chi-square or Fisher’s exact test. Significant findings are in italics
  2. 2p values from multivariable logistic regression adjusting for other variables in tables
  3. 3The number of comorbidities, sum of 12 patient-reported comorbid conditions: diabetes, hypertension, heart disease, lung disease, thyroid condition, cirrhosis liver, stroke, chronic bronchitis, hepatitis, tuberculosis, and 2 others. AA African American; HW Hispanic Whites; NHW = non-Hispanic Whites; BMI body mass index